Chapter 1. PROFESSIONAL DIAGNOSTICS MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. PROFESSIONAL DIAGNOSTICS MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-110 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. PROFESSIONAL DIAGNOSTICS MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. PROFESSIONAL DIAGNOSTICS MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. PROFESSIONAL DIAGNOSTICS MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. PROFESSIONAL DIAGNOSTICS MARKET– By Product Type
6.1. Immunoassay Systems
6.2. Clinical Chemistry Analyzers
6.3. Molecular Diagnostics Instruments
6.4. Hematology Analyzers
6.5. Microbiology Systems
6.6. Coagulation Analyzers
6.7. Blood Gas Analyzers
6.8. Urinalysis Analyzers
6.9. Others
Chapter 7. PROFESSIONAL DIAGNOSTICS MARKET– By Application
7.1. Infectious Diseases
7.2. Oncology
7.3. Cardiology
7.4. Neurology
7.5. Others
Chapter 8. PROFESSIONAL DIAGNOSTICS MARKET– By End User
8.1. Hospitals
8.2. Diagnostic Laboratories
8.3. Academic and Research Centers
8.4. Others
Chapter 9. PROFESSIONAL DIAGNOSTICS MARKET– By Region
9.1. North America
9.2. Europe
9.3. The Asia Pacific
9.4. Latin America
9.5. Middle-East and Africa
Chapter 10. PROFESSIONAL DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
10.1. Company 1
10.2. Company 2
10.3. Company 3
10.4. Company 4
10.5. Company 5
10.6. Company 6
10.7. Company 7
10.8. Company 8
10.9. Company 9
10.10. Company 10
2850
5250
4500
1800